Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death 3. The Job Market for 2008-2009: Compensation 4. Renal Artery Stenosis 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Delayed neutrophil apoptosis in patients with unstable angina: relation to C-reactive protein and recurrence of instability
European Heart Journal, 06/30/09
Biasucci LM et al. – Findings show delayed polymorphonuclear neutrophils (PMNs) apoptosis in unstable angina (UA). This alteration may be involved in persistence of inflammatory activation and affects recurrence of instability.
Methods- Study of spontaneous PMNs apoptosis in UA and its association with recurrence of instability
- Compared PMNs apoptotic rate at 4 hr and 24 hr in pts with UA, stable angina (SA), and controls (H) with 2 different protocols by flow cytometry
- Measurement of apoptotic rate of isolated PMNs (Protocol 1) in 30 UA pts, 13 SA pts, and 34 H; and apoptosis of PMNs in whole blood culture (Protocol 2) in further 10 UA pts, 7 SA pts, and 6 H
- Measurement of serum high-sensitivity C-reactive protein
- Decreased apoptotic rate for PMNs of UA pts vs with SA pts and H at 4 hr in Protocol 1 and at 24 hr in Protocol 2
- In overall population, negative correlation between apoptotic rate at 4 hr and high-sensitivity C-reactive protein levels
- Among 40 pts with UA, 6 had early recurrence of symptoms
- For pts with early recurrence of symptoms apoptotic rate significantly reduced vs UA pts without recurrence of symptoms
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial
The Lancet, 10/27/09
Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis
Arthritis Care and Research , 11/03/09
Benefits and Difficulties in Measuring HDL Subfractions and Human Paraoxonase-1 Activity During Statin Treatment
Cardiovascular Drugs and Therapy, 11/03/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


